Key facts
as of Sep 2026- Candid Therapeutics’s last known valuation is $657.0M.
- It has raised $445.0M across 1 recorded rounds; the latest was Early Stage VC (Series B) ($370.0M) in Aug 2024.
- Notable investors include Fidelity Management & Research Company, Qiming Venture Partners, OrbiMed, Franklin Resources, Venrock — 21 tracked in total.
- 3 institutional filers report fund marks on Candid Therapeutics across 28 filings.
- Candid Therapeutics has filed 1 Form D with the SEC, most recently Sep 2024 ($206.2M sold to 33 investors).
- Status: Privately Held (backing).
PA Mark — composite indicative price
LOW confidence~$4per share
as of Sep 2026 · the exact daily mark is a member feature
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 21 names
- ·Watchlist + deal alerts for Candid Therapeutics
Create free account
No card required
Recorded secondary trades
No prints on record
No secondary trades in Candid Therapeutics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
3 filers · latest Jun 20263 SEC-registered funds reported 28 fair-value marks on Candid Therapeutics between Apr 2025 and Jun 2026. Filer-level marks and implied $/share are available to Pro members.
Funding rounds
1 roundsAug 2024Early Stage VC (Series B)$370.0M▮
About Candid Therapeutics
Operator of a biotechnology research designed to create novel, easy-to-administer therapies for autoimmune diseases. The company offers advanced T-cell engager antibodies, precisely redirecting T-cells to selectively eliminate autoreactive B-cells, enabling patients with autoimmune diseases to experience transformative efficacy and improved therapeutic outcomes.
- Industry
- Drug Discovery
- Sector
- Healthcare
- HQ
- San Diego, CA, United States
- Founded
- 2024
- Employees
- 35
- Website
- candidrx.com/
- Ownership
- Privately Held (backing)